Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Vives Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 27
Average round size
info
The average size of a deal this fund participated in
$15M
Portfolio companies 13
Rounds per year 2.08
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.52
Exits 1
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Wellness
  • Dietary Supplements
  • AgTech
Summary

Vives Fund is the famous VC, which was founded in 2004. The company was established in Europe in Belgium. The leading representative office of defined VC is situated in the Louvain-la-neuve.

Among the most popular portfolio startups of the fund, we may highlight Tessares, Keemotion, Olygose. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are iOS, Nutrition. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Vives Fund, startups are often financed by XMP Business Angels, Investment Arm, Proximus Group, KREAXI. The meaningful sponsors for the fund in investment in the same round are S.R.I.W., Nivelinvest, Iris Capital. In the next rounds fund is usually obtained by R/GA Ventures, Global Sports Venture Studio, Pincus Capital Management.

The high activity for fund was in 2017. The common things for fund are deals in the range of 5 - 10 millions dollars. Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.

We also calculated 1 valuable employee in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Vives Fund:
Typical Co-investors
Vives Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Vives Fund:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Black Powder -
Daum-Kakao Youth Growth Fund -
FinStart Nordic -
Health Evolution Partners California, San Francisco, United States
Humania Assurance Canada, Quebec, Saint-hyacinthe
Insight Investment England, London, United Kingdom
Investing Profit Wisely -
Joyful Ascent -
NDCapital California, Los Angeles, United States
YYX Capital England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Sunrise

Health Care
Lifestyle
Medical Device
Wellness
$20M09 Mar 2023 Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Novadip Biosciences

Biotechnology
Health Care
Medical
Therapeutics
$28M03 Nov 2022 Belgium, Walloon Brabant, Belgium

BOTALYS

AgTech
Biotechnology
Dietary Supplements
Health Care
Nutraceutical
Wellness
$7M04 Oct 2022 Ghislenghien, Hainaut, Belgium

Spinovit

01 Jan 2022 -

Sunrise

Health Care
Lifestyle
Medical Device
Wellness
$7M15 Dec 2021 Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Novadip Biosciences

Biotechnology
Health Care
Medical
Therapeutics
$22M28 Oct 2021 Belgium, Walloon Brabant, Belgium

Aphea.Bio

Agriculture
Biotechnology
Chemical
$21M14 Apr 2021 Ghent, East Flanders, Belgium

Aphea.Bio

Agriculture
Biotechnology
Chemical
$4M01 Apr 2021 Ghent, East Flanders, Belgium

Syndesi Therapeutics

Biotechnology
Health Care
$7M28 Sep 2020 Belgium, Limburg, Belgium

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Vives Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 27
Average round size 15M
Rounds per year 2.08
Peak activity year 2020
Lead investments 0
Follow on index 0.52
Exits 1
Group Appearance index 0.85

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Sunrise

Health Care
Lifestyle
Medical Device
Wellness
$20M09 Mar 2023 Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Novadip Biosciences

Biotechnology
Health Care
Medical
Therapeutics
$28M03 Nov 2022 Belgium, Walloon Brabant, Belgium

BOTALYS

AgTech
Biotechnology
Dietary Supplements
Health Care
Nutraceutical
Wellness
$7M04 Oct 2022 Ghislenghien, Hainaut, Belgium

Spinovit

01 Jan 2022 -

Sunrise

Health Care
Lifestyle
Medical Device
Wellness
$7M15 Dec 2021 Brussels, Brussels Hoofdstedelijk Gewest, Belgium

Novadip Biosciences

Biotechnology
Health Care
Medical
Therapeutics
$22M28 Oct 2021 Belgium, Walloon Brabant, Belgium

Aphea.Bio

Agriculture
Biotechnology
Chemical
$21M14 Apr 2021 Ghent, East Flanders, Belgium

Aphea.Bio

Agriculture
Biotechnology
Chemical
$4M01 Apr 2021 Ghent, East Flanders, Belgium

Syndesi Therapeutics

Biotechnology
Health Care
$7M28 Sep 2020 Belgium, Limburg, Belgium
Crunchbase icon

Content report

The following text will be sent to our editors: